Skip to main content
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp — Investor Relations & Filings

Ticker · NMTC ISIN · US64130M2098 US Manufacturing
Filings indexed 632 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country US United States of America
Listing US NMTC

About NEUROONE MEDICAL TECHNOLOGIES Corp

https://nmtc1.com/

NeuroOne Medical Technologies Corp. is a medical technology company developing and commercializing solutions based on its proprietary thin-film electrode platform. The company provides minimally invasive and high-definition devices for diagnostic and therapeutic neurological applications, including brain recording, mapping, stimulation, and radiofrequency (RF) ablation. Its primary focus is on conditions such as drug-resistant epilepsy and the neurostimulation market. Key products include the Evo® sEEG and Cortical electrodes for brain monitoring and the OneRF™ Ablation System, an FDA-cleared device that combines stereoelectroencephalography (sEEG) recording with RF ablation capabilities for functional neurosurgical procedures. The company's technology aims to improve surgical care options and outcomes for patients with neurological disorders.

Recent filings

Filing Released Lang Actions
NeuroOne(R) Announces Chief Financial Officer Succession Plan
Regulatory Filings
2026-04-30 English
8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Regulatory Filings
2026-04-30 English
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
Earnings Release Classification · 1% confidence The document is a press release announcing the date and time of NeuroOne’s fiscal Q2 2026 financial results release and earnings conference call. It does not contain full financial statements but is clearly an earnings announcement for a quarterly period. This matches the definition of an Earnings Release (ER). Q2 2026
2026-04-28 English
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
Regulatory Filings Classification · 1% confidence The document is not a financial report, earnings release, management change, or any formal SEC filing. It is a press release announcing a corporate collaboration and product development update. It does not fit specialized categories like earnings, M&A, dividends, share issues, or governance statements. Therefore, it falls into the fallback Regulatory Filings category for miscellaneous corporate announcements (RNS).
2026-04-15 English
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
Share Issue/Capital Change Classification · 1% confidence The document is a corporate press release announcing a 1-for-6 reverse stock split (a capital structure change) effective on specified dates to regain Nasdaq compliance. It is not an earnings release, annual/regulatory report, or management change notice. It directly concerns a stock split, which falls under “Share Issue/Capital Change” (Code: SHA).
2026-04-14 English
8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Regulatory Filings
2026-04-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.